Related Experiment Videos
Campylobacter colitis
Journal of Clinical Pathology
|October 1, 1979
Abstract:
A patient is described in whom a campylobacter enteritis closely resembled ulcerative colitis on clinical, sigmoidoscopic, and histological grounds. Selective stool culture techniques may be necessary to differentiate campylobacter colitis from ulcerative colitis proper.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia.
Clinical and experimental immunology·2008
EpCAM and gpA33 are markers of Barrett's metaplasia.
Journal of clinical pathology·2006
CDX1 is an important molecular mediator of Barrett's metaplasia.
Proceedings of the National Academy of Sciences of the United States of America·2005
Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience.
Journal of the Royal College of Surgeons of Edinburgh·2002
Audit of a nurse endoscopist based one stop dyspepsia clinic.
Postgraduate medical journal·2002
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes.
American journal of human genetics·2001
Ancillary testing in paediatric non-CNS solid tumours: a real-world comparison with WHO criteria.
Journal of clinical pathology·2026
No eosinophilic and lymphocytic infiltration in lower oesophageal sphincter biopsies from achalasia patients.
Journal of clinical pathology·2026
Deep learning techniques in predicting BRAF mutation status in cutaneous melanoma from histopathologic images.
Journal of clinical pathology·2026
ALK overexpression without rearrangement widely exists in EWSR1/FUS-rearranged soft tissue tumours.
Journal of clinical pathology·2026
The Mediating Role of Patient Activation in the Association Between Illness Perception and Self-Management Behavior Among Patients with Oral Cancer.
Patient preference and adherence·2026
Nanosystem-Mediated Intercellular Crosstalk Modulation in the Tumor Microenvironment for Enhanced Cancer Immunotherapy.
Drug design, development and therapy·2026